1. "The cumulative incidence of cervical cancer was 47 cases per 100,000 persons among women who had been vaccinated and 94 cases per 100,000 persons among those who had not been vaccinated." This was then adjusted for age at follow-up and covariates (county of residence, and parental characteristics, including education, household income, mother’s country of birth, and maternal disease history). Resulting in: "After adjustment for all covariates, the incidence rate ratio was 0.12 (95% CI, 0.00 to 0.34) among women who had been vaccinated before the age of 17 years and 0.47 (95% CI, 0.27 to 0.75) among women who had been vaccinated at the age of 17 to 30 years."
2. No mention that the study only follows girls until the age of 31? For example, if vaccination just delays onset of cervical cancer then we could see more cases in vaccinated populations in the future
3. This study was using the endpoint out cervical cancer incidence in individuals vs. previous studies looking at prevention of infection with the virus. Few thoughts for future studies:
a) Continuing to follow the same women over a longer time period would be valuable
b) Showing rates per person-year/decade etc. instead of risks to account for time of enrolment into the study
c) Conducting a similar study in another country to understand if the findings (e.g., preferred age window for vaccination) hold there (or if vaccination should be younger due to potentially earlier exposure to HPV).
Welcome to feedback - not sure on 2 and 3!